Video Experimental Relacionado
Updated: Sep 12, 2026
19:16
The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Caracterización e inhibición de una serina peptidasa inactivadora de la colecistoquinina
C Rose1, F Vargas, P Facchinetti
1Unité de Neurobiologie et Pharmacologie de l'INSERM, Centre Paul Broca, Paris, France.
Nature
|April 4, 1996
Resumen
Los investigadores identificaron una nueva peptidasa que inactiva la colecistoquinina (CCK). Esta enzima, la tripeptidil peptidasa II, juega un papel en la regulación de la CCK y la saciedad, y su inhibición muestra efectos pro-saciantes.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- La neurociencia es la neurociencia.
- Enzimología Enzimología.
Sus antecedentes:
- La colecistoquinina (CCK) es una hormona peptídica intestino-cerebral clave involucrada en la saciedad y la digestión.
- Los mecanismos que regulan la inactivación de CCK y sus roles fisiológicos precisos siguen siendo incompletamente entendidos.
- La tripeptidil peptidasa II (TPP-II) es una enzima citosólica con funciones en gran parte desconocidas.
Objetivo del estudio:
- Para identificar la peptidasa responsable de la inactivación de la colecistoquinina (CCK).
- Caracterizar las propiedades y la localización celular de esta enzima inactivadora de CCK.
- Investigar el potencial de inhibir esta peptidasa para modular la actividad de CCK y la saciedad.
Principales métodos:
- Purificación e identificación de la peptidasa inactivadora de CCK de fuentes celulares.
- Caracterización de la enzima como una isoforma unida a la membrana de la tripeptidilpeptidasa II (TPP-II).
- Diseño y aplicación de la butabindida, un inhibidor específico de la peptidasa.
Principales resultados:
- La peptidasa inactivadora de CCK fue identificada como una isoforma unida a la membrana de la tripeptidil peptidasa II (TPP-II).
- Esta peptidasa se detectó tanto en las neuronas sensibles a CCK como en las células no neuronales.
- El inhibidor específico butabindida protegió con éxito la CCK endógena de la inactivación.
- La administración de Butabindida demostró efectos pro-satiantes mediados a través del receptor CCKA.
Conclusiones:
- La tripeptidil peptidasa II (TPP-II) es una enzima crucial en la inactivación de la colecistoquinina (CCK).
- La isoforma TPP-II unida a la membrana está estratégicamente localizada para regular la señalización de CCK tanto en tejidos neuronales como no neuronales.
- La inhibición de TPP-II representa una estrategia terapéutica viable para mejorar la saciedad mediada por CCK.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:29Intestinal Phase of Digestion
The intestinal phase of digestion is the third and final stage of the digestive process, occurring after the cephalic and gastric phases. It begins when chyme, a partially digested mixture of food and digestive enzymes, enters the small intestine from the stomach. This phase is crucial for nutrient absorption and involves complex hormonal and enzymatic interactions.
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...